Home
TECH
TECH News

Latest Bio-Techne Corp (TECH) News on November 27, 2025

Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)

Simply Wall St.

7 days ago

Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)

MT Newswires

7 days ago

Argus Adjusts Price Target on Bio-Techne to $68 From $65, Maintains Buy Rating

Argus Research

7 days ago

Analyst Report: Bio-Techne Corp

Argus Research

7 days ago

Market Digest: ACM, NVDA, TECH, DLR, KHC, HUBS

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

PR Newswire

10 days ago

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

S&P 500 Stocks: These 5 Lead As Index Hits Record High

Investor's Business Daily

2 months ago

S&P 500 Stocks: These 5 Lead As Index Hits Record High

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know

StockStory

2 months ago

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know

Could Spatial Biology Advances Shape Bio-Techne's (TECH) Long-Term Position in Precision Medicine?

Simply Wall St.

2 months ago

Could Spatial Biology Advances Shape Bio-Techne's (TECH) Long-Term Position in Precision Medicine?

3 Low-Volatility Stocks That Concern Us

StockStory

2 months ago

3 Low-Volatility Stocks That Concern Us

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

StockStory

2 months ago

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

Bio-Techne (TECH) Shares Skyrocket, What You Need To Know

StockStory

2 months ago

Bio-Techne (TECH) Shares Skyrocket, What You Need To Know

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics

Insider Monkey

2 months ago

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics

Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?

Zacks

2 months ago

Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?

Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH)

StockStory

2 months ago

Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH)

MT Newswires

2 months ago

MDxHealth Closes $15 Million Exosome Diagnostics Acquisition From Bio-Techne

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

GlobeNewswire

2 months ago

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

Insider Monkey

2 months ago

Here’s Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne’s (TECH) Long-Term Growth Profile

The three-year earnings decline is not helping Bio-Techne's (NASDAQ:TECH share price, as stock falls another 5.8% in past week

Simply Wall St.

2 months ago

The three-year earnings decline is not helping Bio-Techne's (NASDAQ:TECH share price, as stock falls another 5.8% in past week

Argus Research

3 months ago

Analyst Report: Bio-Techne Corp

Argus Research

3 months ago

Market Update: CPRT, TECH, TSN, LULU

Why Bio-Techne (TECH) Shares Are Sliding Today

StockStory

3 months ago

Why Bio-Techne (TECH) Shares Are Sliding Today

Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know

StockStory

3 months ago

Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know

CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls

The Fly

3 months ago

CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls

Bio-Techne Stock: Analyst Estimates & Ratings

Barchart

3 months ago

Bio-Techne Stock: Analyst Estimates & Ratings

Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development

Insider Monkey

5 months ago

Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development

Is Bio-Techne Stock Underperforming the Nasdaq?

Barchart

5 months ago

Is Bio-Techne Stock Underperforming the Nasdaq?

MT Newswires

5 months ago

Bio-Techne, US Pharmacopeia Partner to Distribute Reference Standards

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

PR Newswire

5 months ago

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts

StockStory

6 months ago

TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

PR Newswire

6 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

MT Newswires

6 months ago

Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $70

3 of Wall Street’s Favorite Stocks with Mounting Challenges

StockStory

6 months ago

3 of Wall Street’s Favorite Stocks with Mounting Challenges

Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1

StockStory

6 months ago

Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1

MT Newswires

6 months ago

Argus Adjusts Price Target on Bio-Techne to $65 From $90

Argus Research

6 months ago

Analyst Report: Bio-Techne Corp

Argus Research

6 months ago

Market Digest: MKL, ADSK, AZO, CLX, HPQ, TECH, LYB

MT Newswires

6 months ago

Wells Fargo Initiates Bio-Techne at Overweight With $59 Price Target

Bio-Techne Corporation (TECH): A Bull Case Theory

Insider Monkey

6 months ago

Bio-Techne Corporation (TECH): A Bull Case Theory

Is Bio-Techne Stock the Right Pick for Your Portfolio Now?

Zacks

6 months ago

Is Bio-Techne Stock the Right Pick for Your Portfolio Now?

Bio-Techne to Present at Investor Conferences

PR Newswire

6 months ago

Bio-Techne to Present at Investor Conferences

3 Out-of-Favor Stocks Walking a Fine Line

StockStory

6 months ago

3 Out-of-Favor Stocks Walking a Fine Line

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Investopedia

6 months ago

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

What Makes Bio-Techne Corporation (TECH) a Compelling Addition?

Insider Monkey

6 months ago

What Makes Bio-Techne Corporation (TECH) a Compelling Addition?

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

PR Newswire

6 months ago

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know

StockStory

7 months ago

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know

Biotech Alert: Searches spiking for these stocks today

TipRanks

7 months ago

Biotech Alert: Searches spiking for these stocks today

MT Newswires

7 months ago

Benchmark Adjusts Bio-Techne Price Target to $75 From $95

MT Newswires

7 months ago

Stifel Nicolaus Adjusts Bio-Techne Price Target to $60 From $75, Maintains Hold Rating

MT Newswires

7 months ago

Bio-Techne Collaborates With Genome Engineering Firm Kytopen

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

PR Newswire

7 months ago

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

MT Newswires

7 months ago

Citigroup Adjusts Bio-Techne Price Target to $55 From $70, Maintains Neutral Rating

MT Newswires

7 months ago

Deutsche Bank Adjusts Bio-Techne Price Target to $70 From $84, Maintains Buy Rating

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

PR Newswire

7 months ago

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

MT Newswires

7 months ago

RBC Cuts Price Target on Bio-Techne to $63 From $72, Keeps Sector Perform Rating

Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...

GuruFocus.com

7 months ago

Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...

Thomson Reuters StreetEvents

7 months ago

Q3 2025 Bio-Techne Corp Earnings Call

Morningstar Research

7 months ago

Analyst Report: Bio-Techne Corporation

Bio Techne (TECH) Fell on Negative Funding Environment

Insider Monkey

7 months ago

Bio Techne (TECH) Fell on Negative Funding Environment

MT Newswires

7 months ago

Bio-Techne Approves $500 Million Share Buyback Program, Keeps Quarterly Dividend at $0.08 per Share

Is the Options Market Predicting a Spike in BioTechne Stock?

Zacks

7 months ago

Is the Options Market Predicting a Spike in BioTechne Stock?

MT Newswires

7 months ago

Bio-Techne Fiscal Q3 Non-GAAP Earnings, Sales Increase

Bio-Techne (NASDAQ:TECH) Posts Q1 Sales In Line With Estimates, Stock Soars

StockStory

7 months ago

Bio-Techne (NASDAQ:TECH) Posts Q1 Sales In Line With Estimates, Stock Soars

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

PR Newswire

7 months ago

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

PR Newswire

7 months ago

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

PR Newswire

7 months ago

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

Earnings To Watch: Bio-Techne (TECH) Reports Q1 Results Tomorrow

StockStory

7 months ago

Earnings To Watch: Bio-Techne (TECH) Reports Q1 Results Tomorrow

Should You Hold Bio-Techne Corp. (TECH) For the Long Term?

Insider Monkey

7 months ago

Should You Hold Bio-Techne Corp. (TECH) For the Long Term?

TECH Gears Up to Report Q3 Earnings: Here's What to Expect

Zacks

7 months ago

TECH Gears Up to Report Q3 Earnings: Here's What to Expect

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

PR Newswire

7 months ago

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

Bio-Techne Corporation (TECH) Slid Due to NIH’s Funding Concerns

Insider Monkey

7 months ago

Bio-Techne Corporation (TECH) Slid Due to NIH’s Funding Concerns

3 Healthcare Stocks Facing Headwinds

StockStory

7 months ago

3 Healthcare Stocks Facing Headwinds

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

PR Newswire

7 months ago

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

PR Newswire

7 months ago

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

StockStory

7 months ago

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

StockStory

7 months ago

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

MT Newswires

7 months ago

Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $95, Keeps Outperform Rating

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

PR Newswire

7 months ago

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

Novavax slides after RFK Jr. casts doubts about COVID vaccine

TipRanks

8 months ago

Novavax slides after RFK Jr. casts doubts about COVID vaccine

Morningstar Research

8 months ago

Analyst Report: Bio-Techne Corporation

Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?

Zacks

8 months ago

Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?

Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks

StockStory

8 months ago

Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks

Apple, Starbucks upgraded: Wall Street's top analyst calls

The Fly

8 months ago

Apple, Starbucks upgraded: Wall Street's top analyst calls

MT Newswires

8 months ago

KeyBanc Downgrades Bio-Techne to Sector Weight From Overweight

Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

StockStory

8 months ago

Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

Morningstar Research

8 months ago

Analyst Report: Bio-Techne Corporation

MT Newswires

8 months ago

RBC Cuts Price Target on Bio-Techne to $72 From $79, Keeps Sector Perform Rating

A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack

StockStory

8 months ago

A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack

3 Small-Cap Stocks with Mounting Challenges

StockStory

8 months ago

3 Small-Cap Stocks with Mounting Challenges

MT Newswires

8 months ago

Evercore ISI Adjusts Bio-Techne Price Target to $70 From $75, Maintains Outperform Rating

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

PR Newswire

8 months ago

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

MT Newswires

8 months ago

RBC Trims Price Target on Bio-Techne to $79 From $80, Maintains Sector Perform Rating

Bio-Techne Opens New Customer Experience Centre in Germany

Zacks

8 months ago

Bio-Techne Opens New Customer Experience Centre in Germany

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

StockStory

8 months ago

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

StockStory

8 months ago

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

MT Newswires

8 months ago

Bio-Techne to Open New Customer Facility in Germany

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

PR Newswire

8 months ago

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

2 High-Flying Stocks to Target This Week and 1 to Brush Off

StockStory

8 months ago

2 High-Flying Stocks to Target This Week and 1 to Brush Off

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

PR Newswire

8 months ago

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)

StockStory

8 months ago

Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)

MT Newswires

8 months ago

Evercore ISI Initiates Bio-Techne at Outperform With $75 Price Target

Share on Social Networks: